| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/30/2009 | WO2008100449A4 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury |
| 07/30/2009 | WO2008076810A9 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 07/30/2009 | WO2008052044A3 Use of derivatives of propofol for treating diseases associated with oxidative stress |
| 07/30/2009 | US20090192319 Methods for treating cognitive /attention deficit disorders using tetrahydroindolone analogues and derivatives |
| 07/30/2009 | US20090192312 Brain Function-Improving Agent, and Functional Food Containing the Improving Agent |
| 07/30/2009 | US20090192229 2-Aminoalcohols for the Treatment of Neurodegenerative Diseases |
| 07/30/2009 | US20090192225 Acyloxyalkyl Carbamate Prodrugs of Alpha-Amino Acids, Methods of Synthesis and Use |
| 07/30/2009 | US20090192213 Benzo[b]furane And Benzo[b]thiophene Derivatives |
| 07/30/2009 | US20090192204 N-(2-thiazolyl)-amide derivatives as gsk-3 inhibitors |
| 07/30/2009 | US20090192203 Compounds and compositions as ppar modulators |
| 07/30/2009 | US20090192199 Pharmacological modulation of positive ampa receptor modulator effects on neurotrophin expression |
| 07/30/2009 | US20090192194 Cyclic Amine Derivatives, Processes For Their Preparation, And Pharmaceutical Compositions Containing Them |
| 07/30/2009 | US20090192190 Benzoic Acid Derivatives that are Modulators or Agonists of GlyR |
| 07/30/2009 | US20090192183 Oxymorphone Controlled Release Formulations |
| 07/30/2009 | US20090192181 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 07/30/2009 | US20090192180 Alpha-7 Nicotinic Receptor Agonists and Statins In Combination |
| 07/30/2009 | US20090192179 Chroman derivatives |
| 07/30/2009 | US20090192178 mGluR1 ANTAGONISTS AS THERAPEUTIC AGENTS |
| 07/30/2009 | US20090192177 2-ARYL pyrrologpyrimidines for A1 and A3 receptors |
| 07/30/2009 | US20090192157 Indole compounds and methods for treating visceral pain |
| 07/30/2009 | US20090192156 Phthalazinone derivatives |
| 07/30/2009 | US20090192155 Identification of Compounds Suitable for Treating Ad |
| 07/30/2009 | US20090192142 Use of carbamazepine derivatives for the treatment of agitation in dementia patients |
| 07/30/2009 | US20090192141 Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/30/2009 | US20090192139 Calcitonin gene-related peptide (CGRP) receptor antagonists such as N-[1-(2,3-Difluorobenzyl)-5-oxo-4-(2,22-trifluoroethyl)-1,4-diazepan-6-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide, used for treating headaches |
| 07/30/2009 | US20090192138 compounds |
| 07/30/2009 | US20090192136 Benzoyl-piperazine derivatives |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192097 Synergistic Herbal Composition from Bacopa Species for Management of Neurodegenerative Disorders and a Process of Preparation Thereof |
| 07/30/2009 | US20090192091 Peptide inhibitors of protein kinase C |
| 07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 07/30/2009 | US20090191650 Diagnosing alzheimer's disease via presence of variant brain membrane protein |
| 07/30/2009 | US20090191640 Methods of Screening for Atherosclerosis |
| 07/30/2009 | US20090191291 Cosmetology product for skin and hair |
| 07/30/2009 | US20090191283 Treatment of headaches, neck pain, joint pain and inflammatory-type pain |
| 07/30/2009 | US20090191257 Pain relief lollipop compositions and methods |
| 07/30/2009 | US20090191231 Prevention and treatment of amyloidogenic disease |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | US20090191173 Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1 |
| 07/30/2009 | US20090191159 Multipotent/pluripotent cells and methods |
| 07/30/2009 | US20090191129 Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
| 07/30/2009 | US20090191127 Omentum and use thereof |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/30/2009 | DE202008010830U1 Arzneimittel und Nahrungsergänzungsmittel mit einem Gehalt an stabilisiertem Ubichinol in einer Schutzverpackung Medicines and dietary supplements containing stabilized ubiquinol in protective packaging |
| 07/30/2009 | CA2749742A1 3-(sulfonyl)pyrazolo[1,5-a]pyrimidines - antagonists of serotonin 5-ht6 receptors, methods for their preparation and use |
| 07/30/2009 | CA2713997A1 New 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole compounds and methods of use thereof |
| 07/30/2009 | CA2712910A1 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation |
| 07/30/2009 | CA2712750A1 Aldh-2 inhibitors in the treatment of addiction |
| 07/30/2009 | CA2712347A1 Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them |
| 07/30/2009 | CA2712282A1 Delayed release pharmaceutical composition of duloxetine |
| 07/30/2009 | CA2712222A1 Derivatives of aminoalkanols, method of obtaining of aminoalkanols and their use |
| 07/30/2009 | CA2711713A1 Substituted amino-benzimidazoles, medicaments comprising said compound, their use and their method of manufacture |
| 07/30/2009 | CA2711487A1 Quinolizidinone m1 receptor positive allosteric modulators |
| 07/30/2009 | CA2710538A1 Crystalline form of a (3s)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use |
| 07/30/2009 | CA2709050A1 Sulfonamides as orexin antagonists |
| 07/30/2009 | CA2704128A1 Novel composition for treating the side effects of anticancer treatments |
| 07/29/2009 | EP2083368A1 Database and method for creating a database for classifying and treating physiologic brain imbalances using quantitative eeg |
| 07/29/2009 | EP2083267A1 Diagnosis and treatment of autism using cd38 |
| 07/29/2009 | EP2083014A2 Inhibitors of interleukin-1ß converting enzyme |
| 07/29/2009 | EP2083009A1 Substituted tetrahydroimidazopyridine compounds and their use in medicine |
| 07/29/2009 | EP2083006A1 Oxadiazolones, processes for their preparation and their use as pharmaceuticals |
| 07/29/2009 | EP2082749A2 Prevention and treatment of Alzheimer's disease |
| 07/29/2009 | EP2082747A2 Treatment for Alzeimer's disease |
| 07/29/2009 | EP2082743A2 Inhibitors of GSK-3 and crystal structures of GSK-3beta protein and protein complexes |
| 07/29/2009 | EP2081946A2 Adenosine derivatives for the treatment of pain |
| 07/29/2009 | EP2081938A2 Substituted 8-piperidinyl-2-pyridinyl-pyrimido ý1,2-a¨pirimidin-6-one and 8-piperidinyl-2-pyrimidi nyl-pyrimidoý1,2,-a¨pyrimidin-6-one derivatives |
| 07/29/2009 | EP2081935A1 Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-phenyl}-n-methyl-acetamide |
| 07/29/2009 | EP2081932A2 2-o'-methyladenosine derivatives and their use as agonists or antagonists of an adenosine receptor |
| 07/29/2009 | EP2081907A1 Aryl piperazine derivatives useful for the treatment of neuropsychiatry disorders |
| 07/29/2009 | EP2081904A1 Aripiprazole hemifumarate and process for its preparation |
| 07/29/2009 | EP2081901A1 Novel 2-amino-pyridine derivatives and their use as potassium channel modulators |
| 07/29/2009 | EP2081896A1 Benzoisoindole derivatives and their use as ep4 receptor agonists |
| 07/29/2009 | EP2081892A1 Compounds and methods for treating protein folding disorders |
| 07/29/2009 | EP2081890A1 Arylsulfonyl pyrrolidines as 5-ht6 inhibitors |
| 07/29/2009 | EP2081648A2 Carbamate compounds for use in treating depression |
| 07/29/2009 | EP2081600A1 Combination of nmda- receptor ligand and a compound with 5-ht6 receptor affinity |
| 07/29/2009 | EP2081584A2 Treatment of inflammation, demyelination and neuronal/axonal loss |
| 07/29/2009 | EP2081582A1 Rosemary extracts, dietary and pharmaceutical compositions containing them and their uses |
| 07/29/2009 | EP2081576A2 Method of improving bioavailability for non-sedating barbiturates |
| 07/29/2009 | EP2081571A1 MIXED ORL 1/µ AGONISTS FOR TREATING PAIN |
| 07/29/2009 | EP2081431A1 Organic compounds |
| 07/29/2009 | EP2005951A9 Agent for improving nervous system cell functions |
| 07/29/2009 | EP1979321B1 Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them |
| 07/29/2009 | EP1926712B1 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 07/29/2009 | EP1909790A4 Methods of dosing propofol prodrugs for inducing mild to moderate levels of sedation |
| 07/29/2009 | EP1748982B1 (4, 5, 6, 7-tetrahydro-1-h-indol-7-yl) acetic acid derivatives for treatment of alzheimer's disease |
| 07/29/2009 | EP1732917B1 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 07/29/2009 | EP1713809B1 Dimeric azacyclic compounds and their use |
| 07/29/2009 | EP1461025A4 Treatment of neurodegenerative and cardiovascular disorders |
| 07/29/2009 | EP1397357B1 Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 07/29/2009 | EP1326596B1 Pharmaceutical preparations containing a dibenzocyclooctane lignan derivative for prevention and treatment of neurodegenerative disease |
| 07/29/2009 | EP1292676B1 Mutation associated with epilepsy |
| 07/29/2009 | EP1261601B1 Substituted indoles for modulating nfkb activity |
| 07/29/2009 | EP0854726B2 Stable extract of hypericum perforatum l., process for preparing the same and pharmaceutical compositions |
| 07/29/2009 | CN101495184A Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 07/29/2009 | CN100519749C Agonist anti-TRK-C monoclonal antibodies |
| 07/29/2009 | CN100519554C CCR5 antagonists for treating aids |
| 07/29/2009 | CN100519552C Pyrazole compounds |
| 07/29/2009 | CN100519550C 2-oxo-indole compound having a functtion of inhibiting glycogen synthase kinase-3 |
| 07/29/2009 | CN100519549C Pyrimidine derivatives and pharmaceutical compositions containing the compounds |